Who owns INOZYME PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Inozyme Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Inozyme Pharma stock

Who bought or sold INOZYME PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Pivotal bioVenture Partners Investment Advisor 4.5M $24M 0% Sep 2024
 View chart
Sofinnova Ventures 4.3M $22M 0% Sep 2024
 View chart
Eventide Asset Management 4.1M $22M 5% Sep 2024
 View chart
Rock Springs Capital Management 3.7M $17M 0% Jun 2024
 View chart
BlackRock 3.5M $18M 100% Sep 2024
 View chart
BlackRock 3.3M $15M 8% Jun 2024
 View chart
Samlyn Capital 3.3M $17M -3% Sep 2024
 View chart
Affinity Asset Advisors 2.8M $15M -1% Sep 2024
 View chart
Vanguard Group 2.6M $12M 9% Jun 2024
 View chart
NEA Management Company 2.4M $13M 0% Sep 2024
 View chart
Samsara BioCapital 1.6M $8.2M 0% Sep 2024
 View chart
Sphera Funds Management 1.5M $6.5M 7% Jun 2024
 View chart
Geode Capital Management 1.2M $6.1M 2% Sep 2024
 View chart
Saturn V Capital Management 1.1M $5.1M 100% Jun 2024
 View chart
Blue Owl Capital Holdings 1.1M $5.9M 0% Sep 2024
 View chart
Woodline Partners 1.0M $5.2M 0% Sep 2024
 View chart
State Street Corporation 1.0M $4.5M 14% Jun 2024
 View chart
Knott David M Jr 565k $3.0M 0% Sep 2024
 View chart
Dimensional Fund Advisors 446k $2.3M 17% Sep 2024
 View chart
Northern Trust 439k $2.3M 5% Sep 2024
 View chart
Goldman Sachs Group 362k $1.6M -12% Jun 2024
 View chart
Overbrook Management Corp. 219k $1.1M 0% Sep 2024
 View chart
Pale Fire Capital SE 189k $986k 385% Sep 2024
 View chart
Renaissance Technologies 165k $862k -12% Sep 2024
 View chart
Nuveen Asset Management 161k $718k 0% Jun 2024
 View chart
Bank of New York Mellon 156k $814k -18% Sep 2024
 View chart
Charles Schwab Investment Management 143k $749k 0% Sep 2024
 View chart
Bank of America Corporation 122k $636k -13% Sep 2024
 View chart
Morgan Stanley 79k $352k -36% Jun 2024
 View chart
Rhumbline Advisers 77k $402k 0% Sep 2024
 View chart
Barclays 77k $401k 261% Sep 2024
 View chart
American Century Companies 71k $372k 24% Sep 2024
 View chart
Citadel Advisors 59k $309k 96% Sep 2024
 View chart
Jane Street 50k $259k 7% Sep 2024
 View chart
ExodusPoint Capital Management 48k $251k 100% Sep 2024
 View chart
ALPS Advisors 45k $233k 2% Sep 2024
 View chart
Citigroup 38k $188k 222% Sep 2024
 View chart
GSA Capital Partners 35k $185k -14% Sep 2024
 View chart
Alliancebernstein 33k $146k 79% Jun 2024
 View chart
Deutsche Bank Aktiengesellschaft 31k $163k 76% Sep 2024
 View chart
Two Sigma Advisers 30k $132k -28% Jun 2024
 View chart
Jpmorgan Chase & Co 29k $151k 31% Sep 2024
 View chart
Mirae Asset Global Etfs Holdings 28k $148k 16% Sep 2024
 View chart
MetLife Investment Advisors 28k $146k 0% Sep 2024
 View chart
Wells Fargo & Company 25k $128k 8% Sep 2024
 View chart
Bailard 24k $127k 0% Sep 2024
 View chart
Manufacturers Life Insurance Company 21k $96k 14% Jun 2024
 View chart
Resources Investment Advisors 20k $105k 52% Sep 2024
 View chart
Readystate Asset Management 19k $100k 100% Sep 2024
 View chart
Ing Investment Management 19k $98k 3% Sep 2024
 View chart
T. Rowe Price Associates 17k $87k 1% Sep 2024
 View chart
Parallel Advisors 17k $86k 3% Sep 2024
 View chart
SG Americas Securities 16k $81k 100% Sep 2024
 View chart
Invesco 15k $81k -6% Sep 2024
 View chart
Fox Run Management 15k $80k 100% Sep 2024
 View chart
Palumbo Wealth Management 15k $80k 13% Sep 2024
 View chart
Meeder Asset Management 15k $80k 0% Sep 2024
 View chart
Values First Advisors 15k $77k -14% Sep 2024
 View chart
New York State Common Retirement Fund 13k $70k 0% Sep 2024
 View chart
Florida State Board of Administration 12k $65k 0% Sep 2024
 View chart
Virtu Financial 12k $64k 100% Sep 2024
 View chart
Qube Research & Technologies 11k $48k 100% Jun 2024
 View chart
Tower Research Capital 6.5k $29k 1538% Jun 2024
 View chart
Royal Bank of Canada 5.5k $29k 4% Sep 2024
 View chart
Summit Investment Advisors 4.8k $25k 0% Sep 2024
 View chart
California State Teachers Retirement System 3.7k $20k 0% Sep 2024
 View chart
Amalgamated Bank 1.7k $9.0k 0% Sep 2024
 View chart
Simplex Trading 913.00 $4.0k -16% Sep 2024
 View chart
BFSG 500.00 $2.6k 0% Sep 2024
 View chart
SRS Capital Advisors 475.00 $2.5k 0% Sep 2024
 View chart
Russell Investments 433.00 $1.9k 100% Jun 2024
 View chart
Group One Trading 300.00 $1.6k 0% Sep 2024
 View chart
NISA Investment Advisors 179.00 $936.008900 1093% Sep 2024
 View chart
Sterling Capital Management 164.00 $857.998800 100% Sep 2024
 View chart
Sachetta 100.00 $523.000000 100% Sep 2024
 View chart
Allspring Global Investments Holdings 66.00 $345.001800 0% Sep 2024
 View chart
Advisor Group Holdings 50.00 $262.000000 0% Sep 2024
 View chart
CWM 47.00 $0 236% Sep 2024
 View chart
Us Bancorp 44.00 $230.001200 100% Sep 2024
 View chart
Capital Performance Advisors 35.00 $183.001000 100% Sep 2024
 View chart
Pnc Financial Services 35.00 $183.001000 0% Sep 2024
 View chart
GAMMA Investing 27.00 $140.999400 12% Sep 2024
 View chart

Who sold out of Inozyme Pharma?

Fund or Company Name Date Sold Shares Held Valued At
Millennium Management Jun 2024 1.8M $8.0M
Kennedy Capital Management Mar 2024 438k $3.4M
Parkman Healthcare Partners Mar 2024 223k $1.7M
Laurion Capital Management Jun 2024 127k $564k
Superstring Capital Management Mar 2024 113k $864k
Balyasny Asset Management Mar 2024 31k $240k
Susquehanna International Jun 2024 30k $135k
Two Sigma Investments Mar 2024 30k $229k
Cubist Systematic Strategies Jun 2024 19k $84k
Bridgeway Capital Management Mar 2024 18k $136k
Lido Advisors Mar 2024 17k $131k
Corton Capital Jun 2024 14k $63k
Deerfield Management Company Jun 2024 12k $52k
Prospera Financial Services Jun 2024 11k $50k
AQR Capital Management Jun 2024 11k $48k
Redwood Wealth Management Group Jun 2024 4.5k $20k
ICA Group Wealth Management Mar 2024 85.00 $650.998000